advances in treatment modalities to reduce the risk of gvhd in allografted patients
Published 1 year ago • 59 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
3:50
advances in the prevention and treatment of gvhd
-
1:35
advances in gvhd prophylaxis & treatment
-
2:34
advances in chronic gvhd management
-
4:21
recent advances in the management of acute gvhd
-
0:53
advances in gvhd management and prophylaxis
-
1:09
can adding atg to ptcy further reduce the risk of gvhd?
-
1:53
advances and unmet needs in chronic gvhd
-
2:25
key ebmt guideline updates for the treatment and prophylaxis of gvhd
-
8:37
the pathophysiology of chronic gvhd: current understanding and unanswered questions
-
7:13
living with graft versus host disease on the lungs
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
1:13
promising strategies to prevent gvhd in high-risk patients
-
1:28
improving the management of gvhd
-
1:18
the epidemiology and treatment of chronic gvhd post-allosct
-
4:34
modulation of the microbiota for the treatment of gvhd
-
4:26
management of acute and chronic gvhd
-
2:14
the influence of graft source and composition on gvhd
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
2:37
the role of jak inhibitors in reducing gvhd severity
-
4:04
developments within the gvhd treatment landscape
-
1:08
new drugs for the treatment of gvhd